While chemoradiation is becoming more common for managing head and neck cancers, some patients should have surgery as an initial treatment
Explore this issue:April 2006
TORONTO—There has been a paradigm shift in the management of oropharyngeal and laryngopharyngeal cancer, and top surgeons now opt more frequently for chemoradiation treatment than surgery. At the same time, otolaryngologists–head and neck surgeons need to do their best to determine which patients are not good chemoradiation candidates and should undergo surgery as a first modality.
These were among the key messages presented by a panel of five experts who discussed head and neck cancers at the recent meeting of the Eastern Section of the Triological Society here. The panel, moderated by Ashok Shaha, MD, Professor of Surgery at Memorial Sloan-Kettering Cancer Center in New York City, covered treatment options in response to a series of questions and sample cases presented.